$4.680
+0.061 (+1.30%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTKB Prediction & Forecast by Similar Chart Analysis
Alphio's CTKB stock price prediction model matches the current Cytek Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.69 (+0.31%). The 1-week path is $4.84 (+3.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cytek Biosciences Inc Stock?
Cytek Biosciences Inc is a good buy right now, trading at $4.68 with a current RSI of 55.79, indicating a neutral momentum. The company recently opened an innovation center, which is expected to enhance R&D capabilities and strengthen its market position, contributing to a projected revenue growth of $205 million to $212 million for 2026. However, the main risk is the forward P/E ratio of 370.37, suggesting high expectations for future earnings that may not materialize.
CTKB stock price ended at $4.68 on Friday, after rising +1.30%
Cytek Biosciences Inc (CTKB) last closed at $4.68, gaining +1.30%. These facts feed the 1-day and 1-week CTKB price prediction above.
Forecast Drivers
Cytek Biosciences Inc (CTKB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTKB, ranked by similarity.
Seasonality analysis for CTKB
Historically the probability of a positive August return for CTKB is 0.00%. January offers the highest probability of a positive month at 44.26%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CTKB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.50 | $2.89 | $3.13 | -38.27% |
| Sep 2026 | $1.89 | $2.30 | $2.58 | -50.78% |
| Oct 2026 | $2.03 | $2.36 | $2.43 | -49.62% |
| Nov 2026 | $1.85 | $2.18 | $2.39 | -53.47% |
| Dec 2026 | $2.40 | $2.89 | $3.14 | -38.27% |
In 2026, Cytek Biosciences Inc (CTKB) is projected to range from $1.85 to $3.14.
Cytek Biosciences Inc 2026 monthly forecast
In Aug 2026, Cytek Biosciences Inc is projected to average $2.89, with a low of $2.50 and high of $3.13.
In Sep 2026, Cytek Biosciences Inc is projected to average $2.30, with a low of $1.89 and high of $2.58.
In Oct 2026, Cytek Biosciences Inc is projected to average $2.36, with a low of $2.03 and high of $2.43.
In Nov 2026, Cytek Biosciences Inc is projected to average $2.18, with a low of $1.85 and high of $2.39.
In Dec 2026, Cytek Biosciences Inc is projected to average $2.89, with a low of $2.40 and high of $3.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.